Calcium Channel Blockers and Risk of Lymphedema among Breast Cancer Patients: Nested Case-Control Study.

Amanda J StolarzMrinmayee LakkadV Suzanne KlimbergJacob T Painter

Published in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2019)

CCBs should be avoided or used with caution in breast cancer patients to reduce the risk for developing lymphedema.

Keyphrases